TRIPLEX PHARMA CORP has a total of 14 patent applications. Its first patent ever was published in 1991. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are WAVE LIFE SCIENCES LTD, SYNTHENA AG and GUANGZHOU RIBOBIO CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Norway | 2 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Measuring microorganism processes | |
#6 | Special acyclic compounds | |
#7 | Enzymes | |
#8 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Hogan Michael E | 8 |
#2 | Fennewald Susan | 5 |
#3 | Zendegui Joseph G | 5 |
#4 | Ojwang Joshua O | 5 |
#5 | Rando Robert F | 5 |
#6 | Hogan Michael Edward | 5 |
#7 | Vu Huynh | 3 |
#8 | Revankar Ganapathi Ramakrishna | 3 |
#9 | Rao Takkellapati Sudhakar | 3 |
#10 | Shroff Hitesh Navinchandra | 3 |
Publication | Filing date | Title |
---|---|---|
WO9532628A1 | Oligonucleotide inhibitors of cytokine production and tumors responsive to cytokines | |
AU5986694A | Triplex forming oligonucleotides containing polymeric linkers | |
WO9404550A1 | Cholesteryl-modified triple-helix forming oligonucleotides and uses thereof | |
CA2088787A1 | Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same | |
US5175266A | Nucleosides and oligonucleosides with a phosphate-free internucleoside backbone and process for preparing the same |